Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.

about

Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease

P2860

Q58735160-049F0BB1-0C34-46C2-A89A-518957259998

P2860

Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.

Item

http://www.wikidata.org/entity/Q40083004

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.

@en

type

Item

label

Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.

@en

prefLabel

Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.

@en

P1476

Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.

@en

P2093

Aime K Johnson

http://www.w3.org/2001/XMLSchema#string

Amanda R Taylor

http://www.w3.org/2001/XMLSchema#string

Ashley N Randle

http://www.w3.org/2001/XMLSchema#string

Daniel S Ory

http://www.w3.org/2001/XMLSchema#string

Douglas R Martin

http://www.w3.org/2001/XMLSchema#string

Heather L Gray-Edwards

http://www.w3.org/2001/XMLSchema#string

Miguel Sena-Esteves

http://www.w3.org/2001/XMLSchema#string

Taylor L Voss

http://www.w3.org/2001/XMLSchema#string

Victoria J McCurdy

http://www.w3.org/2001/XMLSchema#string

Xuntian Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan.

Sustained normalization of neurological disease after intracranial gene therapy in a feline model.

AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival

Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.

Prevalence of lysosomal storage disorders.

Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.

Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB

Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-β42, tau, and phospho-tau-181 levels.

GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients.

Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease.

P304

135-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTM.2017.07.005

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28808666

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

5545771

http://www.w3.org/2001/XMLSchema#string

Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.

about

P2860

P2860

Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932